Industrifonden is a venture capital firm based in Stockholm, Sweden, founded in 1979. The firm specializes in early-stage investments in small and medium-sized enterprises, particularly within the technology and life science sectors. It focuses on a wide range of technology areas, including internet and media, information technology, telecommunications, automation, robotics, deep tech, and cleantech. In life sciences, Industrifonden targets pharmaceuticals and medical technology. The firm typically invests between SEK 5 million and SEK 100 million in companies with annual revenues up to SEK 400 million. As an active minority investor, Industrifonden seeks ownership stakes of 15 to 50 percent and often takes a board seat. It provides financing through equity capital, loans, and guarantees, and prefers to co-invest with other regional venture capital firms. The firm's investment strategy aims for exits within five to ten years, either through sales to industry players or initial public offerings. Additionally, Industrifonden maintains offices in Malmö, Linköping, and Gothenburg, contributing to its extensive support for entrepreneurs in Sweden.
Novatron develops a new proprietary fusion power concept together with physicists, engineers, and academia.
Echandia
Venture Round in 2025
Echandia specializes in energy storage solutions and battery systems primarily for maritime transportation, shipping, and heavy-duty applications. The company offers advanced battery technologies, including Lithium-Titanate-Oxide (LTO) systems, which are known for their exceptional safety, rapid charging capabilities—achieving a full charge in approximately 10 minutes—and an impressive lifespan exceeding 30,000 cycles. Their Echandia Energy system is an air-cooled lithium-ion battery designed specifically for long-term maritime use, ensuring both safety and efficiency. Additionally, the Echandia Power system is optimized for hybrid applications, providing high power output for short durations, typically lasting five minutes or less. By focusing on zero-emission energy solutions, Echandia enables clients to adopt sustainable energy sources across various operations, including maritime, rail, and wind power.
Senseworks
Venture Round in 2025
Senseworks is an insight platform that enables colleagues to collaborate effectively with customers by providing a single source of truth for accounting data.
Agteria Biotech
Seed Round in 2025
Agetria Biotech is a biotech startup that specializes in agricultural solutions, providing sustainable feed additives for livestock. The company provides a distinctive feed additive aimed at enhancing the overall health and well-being of livestock, simultaneously decreasing methane emissions. This fosters a more sustainable livestock farming industry, empowering customers to boost animal health, potentially leading to increased productivity and reduced reliance on antibiotics.
Gesynta Pharma
Series B in 2025
Gesynta Pharma AB is a clinical-stage pharmaceutical company based in Solna, Sweden, focused on developing innovative treatments for chronic inflammatory conditions through the inhibition of the pro-inflammatory enzyme microsomal prostaglandin E synthase-1 (mPGES-1). Originating from research at Karolinska Institutet, the company's most advanced drug candidate, vipoglanstat (GS-248), is being developed as a non-hormonal treatment for endometriosis, a prevalent and painful condition affecting many women of reproductive age. In preclinical studies, vipoglanstat has shown significant reductions in endometriotic lesions, pain relief, and improved well-being, with plans for a clinical phase II study underway. Additionally, Gesynta Pharma is preparing to advance another drug candidate, GS-073, into clinical phase I for a different inflammatory condition in 2023. The company aims to provide safe and effective treatment options for patients facing serious diseases related to chronic inflammation. Founded in 2017, Gesynta Pharma is supported by various investors, including Hadean Ventures, Industrifonden, and Linc.
AnaCardio
Series A in 2025
AnaCardio is a clinical stage biopharmaceutical company developing novel drugs to treat heart failure.
Saltx Technology Holding
Post in 2024
SaltX Technology Holding AB specializes in the development and sale of innovative energy storage solutions. The company has created and patented a groundbreaking technology that enables the storage of energy in salt crystals. This unique approach allows for efficient conversion of stored energy into heating and cooling applications. By leveraging the properties of salt, SaltX aims to provide sustainable energy storage options that contribute to the future of energy management.
BOOST Pharma
Venture Round in 2024
BOOST Pharma is a biotechnology research company developing a stem cell therapy for the treatment of osteogenesis imperfecta. It is based on novel mesenchymal stem cells that have high bone-forming capabilities that migrate to the bone of patients where they will engraft, and start bone formation. It was founded in 2019 and is headquartered in Copenhagen, Denmark.
ZeroPoint Technologies
Series A in 2024
ZeroPoint Technologies specializes in advanced memory compression technology that enhances energy efficiency and performance in data centers and smart devices. As energy consumption in the ICT sector rises, ZeroPoint's solutions address the need for improved performance per watt by eliminating unnecessary information from microchips. Their technology, which combines rapid data compression, real-time data compaction, and effective memory management, can deliver up to 50% more performance per watt. This innovation not only allows data centers to optimize energy usage but also enables smart device developers to enhance user experience without sacrificing battery life. With a strong patent portfolio and a foundation rooted in high-performance computing research, ZeroPoint collaborates with leading industry players to integrate its hardware IP into system-on-chip designs. The company, established by experts from academia and industry, has attracted talent from various sectors and successfully raised venture capital to support its growth and technological advancements.
Arevo offers liquid and granular amino acid fertilizer technologies for faster and better plant establishment.
Asgard Therapeutics
Series A in 2024
Asgard Therapeutics is a private biotech company focused on developing innovative cancer immunotherapies through direct cell reprogramming technologies. Emerging as a spin-off from Lund University, the company utilizes its proprietary TrojanDC technology to initiate immune responses by leveraging the unique properties of professional antigen-presenting cells. This approach aims to create efficient and personalized gene therapy products that activate robust anti-cancer immune defenses. By offering off-the-shelf solutions, Asgard Therapeutics seeks to provide new treatment options for patients suffering from cancers that are resistant to traditional therapies, thereby expanding the possibilities for effective cancer treatment.
Apica
Venture Round in 2024
Apica AB is a technology company based in Stockholm, Sweden, with additional offices in London, New York, and Santa Monica. Founded in 2005, it specializes in providing a load testing and synthetic monitoring platform tailored for enterprise needs. Apica's solutions encompass a range of applications, including internal systems, websites, mobile devices, and IoT use cases. The company's flagship products, Apica LoadTest and Apica Synthetic, ensure the performance and uptime of business-critical applications, allowing enterprises to prepare for peak conditions and proactively monitor their systems. Apica's unified platform simplifies data management, enabling real-time analysis of telemetry data and automated root cause analysis. Its tools facilitate efficient troubleshooting and enhance observability, making it easier for organizations to manage complex IT infrastructures while reducing costs and improving performance.
TrusTrace
Series B in 2024
TrusTrace operates a traceability as a service platform designed to enhance transparency and compliance in the fashion supply chain. Founded in 2016 and based in Stockholm, Sweden, with an additional location in Coimbatore, India, the company offers a suite of tools to support product traceability and environmental management. Its primary offerings include T-Tracem, which tracks products from fiber to garment; T-CET, a customer engagement tool; I-CAT, which helps manage the environmental footprint; T-VeM for vendor management; T-BlockS, a blockchain solution for enhanced traceability and collaboration; and T-EMS, an evidence management tool. TrusTrace's technology enables global brands and suppliers to standardize the collection, digitization, and sharing of reliable supply chain data, allowing them to substantiate product claims and ensure regulatory compliance effectively.
Texray
Venture Round in 2023
Texray AB specializes in the development of radiation protection textiles specifically designed for medical practitioners who use X-rays during surgical procedures. The company has created a unique woven material with an attenuating capacity that effectively shields users from harmful radiation. This innovative product not only prioritizes the health and safety of medical professionals but also enhances their ability to perform life-saving interventions. Through its patented technology platform, Texray aims to revolutionize radiation protection in the medical field.
MinervaX
Venture Round in 2023
Minervax is focused on developing a vaccine to prevent infections caused by Group B streptococcus (GBS), which can lead to serious health issues in newborns and adverse pregnancy outcomes. The company is researching a specific fusion protein that has demonstrated the ability to stimulate strong protective immunity against various clinically significant GBS strains. By utilizing this innovative approach, Minervax aims to provide medical professionals with an effective tool to protect newborns from potentially life-threatening bacterial infections associated with GBS.
Fast Travel Games
Venture Round in 2023
Fast Travel Games is a game development studio based in Stockholm, Sweden, specializing in virtual reality (VR) games. Founded by experienced professionals from notable studios such as EA DICE, Rovio, and Avalanche, the company aims to transform the gaming experience through immersive VR environments. They focus on creating games that promote exploration, rich narratives, and social interaction, allowing players to engage with their surroundings and each other in innovative ways. Fast Travel Games is dedicated to delivering engaging experiences that enhance the way players connect with gaming universes.
Pixelgen Technologies
Series A in 2023
Pixelgen Technologies is a company focused on advancing biomedical research and diagnostics through the development of innovative bio-analytical tools. Founded in 2020 and based in Sweden, the firm specializes in creating novel analytical methods and products that enhance the understanding of biological processes. These tools are designed to provide researchers and drug developers with valuable insights into biomedicine, ultimately aiming to improve health outcomes. By delivering advanced solutions for biomedical analysis, Pixelgen Technologies plays a crucial role in supporting scientific discovery and development in the healthcare sector.
AlixLabs
Seed Round in 2023
AlixLabs specializes in nanostructure fabrication using atomic layer etching (ALE) technology. This innovative approach enables the production of nanostructures with sizes less than 20 nanometers, surpassing the limitations of traditional optical and electron beam lithography. By employing a damage-free etching process, AlixLabs facilitates the manufacturing of extremely small structures with high precision and efficiency, which is particularly beneficial for the semiconductor industry. The company's methods may also support the economically viable scaling of transistor channels for sub-20 nanometer technology nodes, positioning AlixLabs as a key player in advancing nanoelectronics.
Novatron
Seed Round in 2023
Novatron is focused on developing a proprietary fusion power concept aimed at producing clean, sustainable energy. Collaborating with physicists, engineers, and academic institutions, the company seeks to create an energy system that not only reduces reliance on fossil fuels but also minimizes greenhouse gas emissions. By advancing fusion energy technology, Novatron aims to provide abundant and renewable energy solutions, contributing to a more sustainable future for humanity.
Apica
Venture Round in 2023
Apica AB is a technology company based in Stockholm, Sweden, with additional offices in London, New York, and Santa Monica. Founded in 2005, it specializes in providing a load testing and synthetic monitoring platform tailored for enterprise needs. Apica's solutions encompass a range of applications, including internal systems, websites, mobile devices, and IoT use cases. The company's flagship products, Apica LoadTest and Apica Synthetic, ensure the performance and uptime of business-critical applications, allowing enterprises to prepare for peak conditions and proactively monitor their systems. Apica's unified platform simplifies data management, enabling real-time analysis of telemetry data and automated root cause analysis. Its tools facilitate efficient troubleshooting and enhance observability, making it easier for organizations to manage complex IT infrastructures while reducing costs and improving performance.
Fishbrain
Venture Round in 2023
Fishbrain is a mobile app and social network designed for fishing enthusiasts. It offers users tools, insights, and support to enhance their fishing experiences. The app features an interactive map that helps anglers discover new fishing locations and track what others are catching, including the bait used. Additionally, Fishbrain emphasizes responsible fishing practices by promoting catch and release methods and the sustainable harvesting of fish species. The platform aggregates data on fishing catches from around the world, fostering a community where users can connect and share their fishing experiences.
Virkesbörsen
Venture Round in 2023
Virkesbörsen has developed a digital marketplace for buying and selling wood in Sweden.
Hopsworks
Series B in 2023
Hopsworks, founded in 2016 and based in Stockholm, Sweden, is a developer of a data platform that focuses on artificial intelligence and machine learning. The company offers Hops Enterprise Services, which utilizes deep learning, stream processing, and SQL capabilities. Hopsworks provides an on-premise data management and data science platform called Hopsworks Enterprise, which includes tools for planning, pricing, and calculating return on investment for data scientists. The platform is designed to support the development and management of feature, training, and inference pipelines at scale, catering to diverse data teams and sources. Hopsworks specializes in technologies such as TensorFlow, Flink, MySQL, and HDFS, enabling clients to implement AI solutions for complex business challenges with optimal performance and availability.
Soundtrack Your Brand
Venture Round in 2023
Soundtrack Your Brand is a business-to-business music platform that allows small business owners to create and legally play tailored playlists in their venues. The platform offers a subscription-based service that grants access to a commercial catalog of songs, enabling businesses to play any music they choose without legal concerns. This service helps businesses enhance their digital media presence by curating playlists that suit various settings and events, ensuring a positive experience for both customers and employees. Soundtrack Your Brand aims to simplify the process of music selection for businesses, providing unlimited and customizable playlists during operational hours.
Retein
Venture Round in 2023
Retein is a water purification technology company focused on producing pure water at a low energy cost. Utilizing advanced materials and aquaporin proteins, Retein's technology effectively removes pollutants, including microplastics and pharmaceutical residues, from water. This innovative approach not only ensures the sustainable recovery of valuable resources but also promotes efficiency and cost-effectiveness for clients. By advancing water purification methods, Retein contributes to a resource-efficient and sustainable future.
Open Payments
Venture Round in 2023
Open Payments Europe is a developer of an open banking platform that facilitates secure access to various bank API networks across Europe. Established in 2017 and based in Stockholm, Sweden, the company offers a PSD2 compliant API aggregation platform, ensuring a unified and secure point of access for users. The platform is designed to allow third-party providers and business partners to create and manage their own products and services while maintaining control over the user experience. By using multi-language support and sample integrations, Open Payments enables businesses to seamlessly connect with banks and financial services, thereby enhancing the efficiency of their operations and fostering innovation in the financial sector.
Teitur Trophics
Series A in 2023
Teitur Trophics is a biotech company based in Aarhus, Denmark, established in 2020. The company focuses on developing circular peptides aimed at addressing neurodegenerative diseases. By studying small peptides that interact with receptors crucial for neural function, Teitur Trophics aims to understand the underlying biology and modulate key mechanisms involved in neural activity. This research is intended to support healthcare professionals in creating treatments that can prevent the onset of neurodegenerative conditions through daily injections.
ZeroPoint Technologies
Seed Round in 2023
ZeroPoint Technologies specializes in advanced memory compression technology that enhances energy efficiency and performance in data centers and smart devices. As energy consumption in the ICT sector rises, ZeroPoint's solutions address the need for improved performance per watt by eliminating unnecessary information from microchips. Their technology, which combines rapid data compression, real-time data compaction, and effective memory management, can deliver up to 50% more performance per watt. This innovation not only allows data centers to optimize energy usage but also enables smart device developers to enhance user experience without sacrificing battery life. With a strong patent portfolio and a foundation rooted in high-performance computing research, ZeroPoint collaborates with leading industry players to integrate its hardware IP into system-on-chip designs. The company, established by experts from academia and industry, has attracted talent from various sectors and successfully raised venture capital to support its growth and technological advancements.
Viking Analytics
Series A in 2023
Viking Analytics AB, based in Gothenburg, Sweden, develops advanced software solutions tailored for the manufacturing, chemical, and process industries. Established in 2012, the company specializes in its MultiViz analytics software, which assists industrial firms in preparing, analyzing, and organizing sensor data and condition monitoring information. This tool enables users to visualize data effectively, detect patterns, and monitor machine performance with greater reliability. Since 2018, Viking Analytics has focused on enhancing the capabilities of maintenance firms, original equipment manufacturers, and system integrators by identifying machines that require attention and providing insights into the reasons for their condition. By utilizing feedback from experts, the software continuously improves its performance, reducing false alarms and eliminating the need for companies to maintain their own artificial intelligence teams. Overall, Viking Analytics contributes to process optimization and minimizes unplanned maintenance interruptions through advanced anomaly detection and predictive analytics.
EnginZyme
Series B in 2022
EnginZyme AB is a biotechnology company based in Stockholm, Sweden, founded in 2014. The company specializes in biocatalysis and a cell-free synthetic biology platform to create sustainable alternatives to conventional materials such as plastics, nylons, and rubbers. EnginZyme's innovative approach focuses on biomanufacturing techniques that promote green chemistry across various industries, including pharmaceuticals, food, chemicals, flavors, and fragrances. By utilizing patented cell-free technology, EnginZyme aims to replace traditional fossil-based manufacturing, thus facilitating the shift toward environmentally friendly production methods. The company has gained recognition for its contributions to sustainability, being named a Global Cleantech 100 company and recognized as a Technology Pioneer by the World Economic Forum. EnginZyme is supported by a diverse group of investors, reflecting its potential impact on addressing climate change and promoting sustainable practices in manufacturing.
MinervaX
Series C in 2022
Minervax is focused on developing a vaccine to prevent infections caused by Group B streptococcus (GBS), which can lead to serious health issues in newborns and adverse pregnancy outcomes. The company is researching a specific fusion protein that has demonstrated the ability to stimulate strong protective immunity against various clinically significant GBS strains. By utilizing this innovative approach, Minervax aims to provide medical professionals with an effective tool to protect newborns from potentially life-threatening bacterial infections associated with GBS.
Occtoo
Seed Round in 2022
Occtoo AB is a software as a service company based in Vellinge, Sweden, that offers an Experience Data Platform aimed at enhancing digital experiences for retailers and brands. Founded in 2019, the platform enables marketers and content managers to easily orchestrate and personalize customer interactions by transforming enterprise data into actionable experience data. Occtoo provides no-code and low-code solutions that facilitate content personalization, dynamic product profiling, and customer insights, while also allowing for real-time data collection across various devices and channels. This technology streamlines the creation of applications and digital experiences, reducing the need for complex integrations. Notable clients include brands such as Cartier, Intersport, Fjällräven, and Filippa K, reflecting the platform's effectiveness in delivering tailored user experiences throughout the customer journey.
KISAB
Venture Round in 2022
KISAB is a partner of Mitronic IT services and is their local provider of office equipment and IT in technical service and sales. They offer sales, service, repairs, and accessories for most brands on the market, including Brother, Canon, Sharp, Olivetti, OKI, Lexmark, HP, Microsoft, and more.
AnaCardio
Series A in 2022
AnaCardio is a clinical stage biopharmaceutical company developing novel drugs to treat heart failure.
Airsonett
Venture Round in 2022
Airsonett is a medical device company focused on developing non-pharmaceutical treatments for allergic asthma and eczema. Its flagship product, the Air4, utilizes patented Temperature-controlled Laminar Airflow (TLA) technology to significantly reduce allergens and airborne irritants in a patient's breathing zone during rest and sleep. This innovative home medical device aims to provide relief for individuals suffering from allergic asthma and atopic eczema, primarily serving patients in Sweden and the UK. By offering a non-invasive solution, Airsonett addresses the need for effective prophylactic treatments without relying on traditional medication.
Nextory AB is a Sweden-based company that specializes in providing a subscription service for access to a diverse collection of e-books and audiobooks through its mobile application. The platform offers users the ability to download and listen to audiobooks or read e-books in PDF format, facilitating a convenient and flexible reading experience on smartphones and tablets. Nextory aims to enhance literary engagement by giving clients a broad catalog of digital content, allowing them to explore new stories and genres.
Elypta
Series A in 2022
Elypta AB is a molecular diagnostic company based in Stockholm, Sweden, specializing in the development of a metabolism-based liquid biopsy platform aimed at the early detection and monitoring of cancer. Founded in 2017, the company focuses on measuring biomarkers in blood and urine, employing machine learning and artificial intelligence algorithms to identify cancer signatures. Elypta is actively conducting the AURORAX clinical trial series to explore applications for its platform, particularly in renal cell carcinoma, while also investigating other cancer indications. The technology includes a new in vitro diagnostic laboratory assay kit, which enables comprehensive profiling of glycosaminoglycan metabolites and supports a range of applications from screening to treatment response monitoring, facilitating earlier interventions in cancer care.
ShardSecure
Series A in 2022
ShardSecure, Inc. is a data protection company that specializes in cloud data security solutions. Founded in 2019 and headquartered in New York, ShardSecure utilizes its proprietary Microshard technology to enhance the security of sensitive data stored and shared in the cloud. This technology fragments data into small pieces that are distributed across multiple cloud environments and combined with false shards, making it nearly impossible for cybercriminals to reassemble the original information. By deploying as a virtual storage appliance, Microshard serves as an application-agnostic solution that provides an additional layer of defense against potential misconfigurations in cloud settings. ShardSecure integrates with major cloud service providers such as AWS, Azure, Google, and IBM, offering enterprises and government agencies a simplified approach to data security without the complexities associated with traditional encryption methods.
Peafowl Plasmonics
Seed Round in 2022
Peafowl Plasmonics specializes in innovative solar cell technology that is highly transparent, efficient, and sustainable. The company has developed plasmonic solar cells capable of absorbing light in various conditions, whether in harsh outdoor environments or low-illumination indoor settings. This technology not only enhances energy efficiency but also allows for the direct integration of sensors into window glass without the need for wires or batteries. By enabling commercial partners and customers to reduce energy consumption and carbon emissions, Peafowl Plasmonics actively contributes to lowering corporate carbon footprints and promoting sustainable energy solutions.
Asgard Therapeutics
Seed Round in 2021
Asgard Therapeutics is a private biotech company focused on developing innovative cancer immunotherapies through direct cell reprogramming technologies. Emerging as a spin-off from Lund University, the company utilizes its proprietary TrojanDC technology to initiate immune responses by leveraging the unique properties of professional antigen-presenting cells. This approach aims to create efficient and personalized gene therapy products that activate robust anti-cancer immune defenses. By offering off-the-shelf solutions, Asgard Therapeutics seeks to provide new treatment options for patients suffering from cancers that are resistant to traditional therapies, thereby expanding the possibilities for effective cancer treatment.
TrusTrace
Series A in 2021
TrusTrace operates a traceability as a service platform designed to enhance transparency and compliance in the fashion supply chain. Founded in 2016 and based in Stockholm, Sweden, with an additional location in Coimbatore, India, the company offers a suite of tools to support product traceability and environmental management. Its primary offerings include T-Tracem, which tracks products from fiber to garment; T-CET, a customer engagement tool; I-CAT, which helps manage the environmental footprint; T-VeM for vendor management; T-BlockS, a blockchain solution for enhanced traceability and collaboration; and T-EMS, an evidence management tool. TrusTrace's technology enables global brands and suppliers to standardize the collection, digitization, and sharing of reliable supply chain data, allowing them to substantiate product claims and ensure regulatory compliance effectively.
Funnel
Series C in 2021
Funnel is a marketing analytics and reporting software that aims to streamline data collection for online advertisers and e-commerce companies. Founded in 2014 by Fredrik Skantze and Per Made, the company provides a platform that integrates with over 400 marketing and advertising sources. This allows businesses to automatically collect and structure advertising performance data, facilitating better decision-making regarding advertising spend and business growth. Funnel enables users to feed data into various tools, including Business Intelligence platforms, Data Warehouses, and visualization tools like Google Data Studio and Google Analytics. The company serves a diverse clientele, including e-commerce businesses, media agencies, brands, B2B enterprises, mobile applications, and gaming companies. Funnel operates from its headquarters in Stockholm, with an additional office in Boston.
ZeroPoint Technologies
Seed Round in 2021
ZeroPoint Technologies specializes in advanced memory compression technology that enhances energy efficiency and performance in data centers and smart devices. As energy consumption in the ICT sector rises, ZeroPoint's solutions address the need for improved performance per watt by eliminating unnecessary information from microchips. Their technology, which combines rapid data compression, real-time data compaction, and effective memory management, can deliver up to 50% more performance per watt. This innovation not only allows data centers to optimize energy usage but also enables smart device developers to enhance user experience without sacrificing battery life. With a strong patent portfolio and a foundation rooted in high-performance computing research, ZeroPoint collaborates with leading industry players to integrate its hardware IP into system-on-chip designs. The company, established by experts from academia and industry, has attracted talent from various sectors and successfully raised venture capital to support its growth and technological advancements.
Limina Investment Management Solution
Series A in 2021
Limina Investment Management Solution (IMS) is a Front-to-Middle Office Solution that let investment managers focus on what matters: producing investment returns with minimal operational risk. The open platform help Asset Managers overcome fragmented workflows and increase confidence in data and oversight. Limina was founded by former investment managers that set out to create a solution to the challenges they faced. The solution now offered by Limina is engineered in Sweden and delivered by industry experts globally.
Hopsworks
Series A in 2021
Hopsworks, founded in 2016 and based in Stockholm, Sweden, is a developer of a data platform that focuses on artificial intelligence and machine learning. The company offers Hops Enterprise Services, which utilizes deep learning, stream processing, and SQL capabilities. Hopsworks provides an on-premise data management and data science platform called Hopsworks Enterprise, which includes tools for planning, pricing, and calculating return on investment for data scientists. The platform is designed to support the development and management of feature, training, and inference pipelines at scale, catering to diverse data teams and sources. Hopsworks specializes in technologies such as TensorFlow, Flink, MySQL, and HDFS, enabling clients to implement AI solutions for complex business challenges with optimal performance and availability.
ShardSecure
Seed Round in 2021
ShardSecure, Inc. is a data protection company that specializes in cloud data security solutions. Founded in 2019 and headquartered in New York, ShardSecure utilizes its proprietary Microshard technology to enhance the security of sensitive data stored and shared in the cloud. This technology fragments data into small pieces that are distributed across multiple cloud environments and combined with false shards, making it nearly impossible for cybercriminals to reassemble the original information. By deploying as a virtual storage appliance, Microshard serves as an application-agnostic solution that provides an additional layer of defense against potential misconfigurations in cloud settings. ShardSecure integrates with major cloud service providers such as AWS, Azure, Google, and IBM, offering enterprises and government agencies a simplified approach to data security without the complexities associated with traditional encryption methods.
Fast Travel Games
Series B in 2021
Fast Travel Games is a game development studio based in Stockholm, Sweden, specializing in virtual reality (VR) games. Founded by experienced professionals from notable studios such as EA DICE, Rovio, and Avalanche, the company aims to transform the gaming experience through immersive VR environments. They focus on creating games that promote exploration, rich narratives, and social interaction, allowing players to engage with their surroundings and each other in innovative ways. Fast Travel Games is dedicated to delivering engaging experiences that enhance the way players connect with gaming universes.
Digip
Seed Round in 2021
Digip is a Swedish legal tech SaaS company that offers trademark accessible and affordable protection, By combining tech, know-how, and investments, Digip creates the most innovative technology on the market to enhance the customer experience, streamline processes and lower the cost of intellectual property protection.
NuvoAir
Series A in 2021
NuvoAir AB, founded in 2015 and based in Stockholm, Sweden, is a medical technology company focused on monitoring lung function through its Air Next home spirometer. The company operates an online platform to provide its products and services. NuvoAir Medical offers a comprehensive care model that integrates advanced monitoring technology and analytics with evidence-based interventions for managing chronic heart and lung conditions. This approach emphasizes personalized care, delivered by a multidisciplinary team, and collaborates with health plans and risk-bearing entities to implement flexible payment arrangements. By focusing on value-based specialty management, NuvoAir aims to improve patient outcomes while reducing healthcare costs.
Exeri
Venture Round in 2021
Exeri AB, founded in 2009 and based in Luleå, Sweden, specializes in transforming traditional electric grids into Smart Grids through its innovative Smart Grid Surveillance (SGS) system. This comprehensive technology digitizes electric grid networks, enabling real-time monitoring and providing network owners with up-to-date information on their systems. Exeri's solution enhances the security of electricity networks by facilitating quick problem detection and reducing power outage durations. Utilizing IoT technology and AI-driven algorithms, the system offers precise error localization, predictive maintenance capabilities, and decision support tools. This not only improves the efficiency of electricity grids but also supports the integration of renewable energy sources and the charging of electric vehicles, contributing to a sustainable energy future.
Lexly
Venture Round in 2021
Lexly is a prominent player in the Nordic legal tech market, offering online legal services that provide specialized legal advice around the clock. The company focuses on various legal matters, including wills, gift deeds, and stockholder agreements. Lexly also features an online legal tool designed to help individuals create their legal documents efficiently. By streamlining the process of obtaining legal assistance, Lexly enables customers to minimize legal costs while enhancing overall efficiency. The group also encompasses brands such as Stirling Blue and Pactumize, further solidifying its position in the industry.
Meniga
Venture Round in 2021
Meniga Ltd is a company that specializes in developing white-label digital banking solutions aimed at enhancing personal finance management. Founded in 2013 and based in London, the company provides a range of services including data aggregation, automated real-time notifications, predictive analytics, and personalized customer engagement. Meniga's platform also offers marketing products that feature card-linked offers and consumer data analytics, helping banks and businesses better understand their customers' financial behaviors. By focusing on advanced data consolidation and meaningful customer interactions, Meniga aims to improve the online and mobile banking experience for financial institutions, ultimately fostering stronger customer relationships and creating new revenue opportunities.
Crosser
Venture Round in 2021
Crosser specializes in the design and development of streaming analytics and integration software suitable for edge, fog, or cloud environments. The Crosser platform facilitates real-time processing of both streaming and batch data, supporting applications in industrial IoT, data transformation, analytics, automation, and integration. By offering real-time analytics and decision-making capabilities, the platform is particularly beneficial for enterprises in sectors such as healthcare, industrial IoT, and smart buildings. This technology helps organizations minimize cloud service usage and reduce bandwidth costs, enhancing operational efficiency and effectiveness.
EnginZyme
Series A in 2021
EnginZyme AB is a biotechnology company based in Stockholm, Sweden, founded in 2014. The company specializes in biocatalysis and a cell-free synthetic biology platform to create sustainable alternatives to conventional materials such as plastics, nylons, and rubbers. EnginZyme's innovative approach focuses on biomanufacturing techniques that promote green chemistry across various industries, including pharmaceuticals, food, chemicals, flavors, and fragrances. By utilizing patented cell-free technology, EnginZyme aims to replace traditional fossil-based manufacturing, thus facilitating the shift toward environmentally friendly production methods. The company has gained recognition for its contributions to sustainability, being named a Global Cleantech 100 company and recognized as a Technology Pioneer by the World Economic Forum. EnginZyme is supported by a diverse group of investors, reflecting its potential impact on addressing climate change and promoting sustainable practices in manufacturing.
MinervaX
Series B in 2020
Minervax is focused on developing a vaccine to prevent infections caused by Group B streptococcus (GBS), which can lead to serious health issues in newborns and adverse pregnancy outcomes. The company is researching a specific fusion protein that has demonstrated the ability to stimulate strong protective immunity against various clinically significant GBS strains. By utilizing this innovative approach, Minervax aims to provide medical professionals with an effective tool to protect newborns from potentially life-threatening bacterial infections associated with GBS.
Avassa
Funding Round in 2020
Avassa is a developer of a distributed cloud management platform focused on managing applications across various edge locations. The platform facilitates secure and remote updates, monitoring, and troubleshooting of edge applications, streamlining application orchestration while adhering to a zero-trust security model. By bridging the gap between containerized application development and operations, Avassa's solution allows businesses to deploy teams, monitor workloads, and manage the lifecycle of edge applications efficiently and securely. This approach empowers organizations to operate at the speed of software while ensuring robust management in diverse environments.
inRiver
Venture Round in 2020
inRiver AB develops a product information management (PIM) software solution that enables branded manufacturers, industrial manufacturers, and retailers to create, manage, and distribute product information effectively. The company serves B2C and B2B multi-channel commerce professionals, enhancing their ability to drive online sales and maintain customer satisfaction. Founded in 2003 and headquartered in Malmö, Sweden, inRiver has established regional offices in Chicago, Amsterdam, and Stockholm, along with sales offices in various global locations. The platform allows organizations to turn product information into strategic assets by uniformly presenting sales materials, such as videos, text, and images, across multiple channels and languages. With over 1,000 brands and 400 customers in 19 countries, inRiver helps businesses increase revenue and strengthen brand equity.
Open Payments
Seed Round in 2020
Open Payments Europe is a developer of an open banking platform that facilitates secure access to various bank API networks across Europe. Established in 2017 and based in Stockholm, Sweden, the company offers a PSD2 compliant API aggregation platform, ensuring a unified and secure point of access for users. The platform is designed to allow third-party providers and business partners to create and manage their own products and services while maintaining control over the user experience. By using multi-language support and sample integrations, Open Payments enables businesses to seamlessly connect with banks and financial services, thereby enhancing the efficiency of their operations and fostering innovation in the financial sector.
Gesynta Pharma
Series C in 2020
Gesynta Pharma AB is a clinical-stage pharmaceutical company based in Solna, Sweden, focused on developing innovative treatments for chronic inflammatory conditions through the inhibition of the pro-inflammatory enzyme microsomal prostaglandin E synthase-1 (mPGES-1). Originating from research at Karolinska Institutet, the company's most advanced drug candidate, vipoglanstat (GS-248), is being developed as a non-hormonal treatment for endometriosis, a prevalent and painful condition affecting many women of reproductive age. In preclinical studies, vipoglanstat has shown significant reductions in endometriotic lesions, pain relief, and improved well-being, with plans for a clinical phase II study underway. Additionally, Gesynta Pharma is preparing to advance another drug candidate, GS-073, into clinical phase I for a different inflammatory condition in 2023. The company aims to provide safe and effective treatment options for patients facing serious diseases related to chronic inflammation. Founded in 2017, Gesynta Pharma is supported by various investors, including Hadean Ventures, Industrifonden, and Linc.
Meniga
Corporate Round in 2020
Meniga Ltd is a company that specializes in developing white-label digital banking solutions aimed at enhancing personal finance management. Founded in 2013 and based in London, the company provides a range of services including data aggregation, automated real-time notifications, predictive analytics, and personalized customer engagement. Meniga's platform also offers marketing products that feature card-linked offers and consumer data analytics, helping banks and businesses better understand their customers' financial behaviors. By focusing on advanced data consolidation and meaningful customer interactions, Meniga aims to improve the online and mobile banking experience for financial institutions, ultimately fostering stronger customer relationships and creating new revenue opportunities.
Trialbee
Venture Round in 2020
Trialbee is an independent software company dedicated to deliver solutions and services to the pharmaceutical industry. The company was founded in 2010 with the development of a method to increase speed and accuracy of patient recruitment to clinical trials.
DbVis Software
Venture Round in 2020
DbVis Software AB, founded in 2003 and based in Stockholm, Sweden, specializes in developing database management and analysis software. Its flagship product, DbVisualizer, serves as a platform-independent tool that connects to various data sources, allowing users to manage database-specific objects and perform tasks such as creating, editing, and compiling procedures, functions, and triggers. The software also facilitates schema exports and the comparison of editors and result sets. DbVis Software emphasizes user feedback in its development process, ensuring that new features are added thoughtfully. The company offers dedicated support directly from its development team, maintaining a transparent and competitive pricing model that includes a free version of DbVisualizer, as well as discounts for educational and non-profit institutions. With over 6 million downloads and adoption by more than 28,000 companies across 145 countries, DbVis Software is committed to providing high-quality tools that enhance the efficiency of database users.
Nextory
Venture Round in 2020
Nextory AB is a Sweden-based company that specializes in providing a subscription service for access to a diverse collection of e-books and audiobooks through its mobile application. The platform offers users the ability to download and listen to audiobooks or read e-books in PDF format, facilitating a convenient and flexible reading experience on smartphones and tablets. Nextory aims to enhance literary engagement by giving clients a broad catalog of digital content, allowing them to explore new stories and genres.
Barnebys
Venture Round in 2020
Barnebys is a leading online search aggregator for art, antiques, and collectibles, founded in Stockholm, Sweden in 2011. The company operates globally, with offices in New York, the UK, France, Spain, and Germany. Barnebys provides a platform that connects buyers and sellers in the auction industry, allowing them to conduct transactions through a user-friendly interface. The service caters to top-tier auctioneers, antique dealers, galleries, as well as regional and local businesses. In addition to its search capabilities, Barnebys offers an extensive free database of auction results and a premium valuation service, enhancing the tools available to its clients. The company continues to explore opportunities for growth and expansion in the auction market.
Elypta
Seed Round in 2020
Elypta AB is a molecular diagnostic company based in Stockholm, Sweden, specializing in the development of a metabolism-based liquid biopsy platform aimed at the early detection and monitoring of cancer. Founded in 2017, the company focuses on measuring biomarkers in blood and urine, employing machine learning and artificial intelligence algorithms to identify cancer signatures. Elypta is actively conducting the AURORAX clinical trial series to explore applications for its platform, particularly in renal cell carcinoma, while also investigating other cancer indications. The technology includes a new in vitro diagnostic laboratory assay kit, which enables comprehensive profiling of glycosaminoglycan metabolites and supports a range of applications from screening to treatment response monitoring, facilitating earlier interventions in cancer care.
Funnel
Series B in 2020
Funnel is a marketing analytics and reporting software that aims to streamline data collection for online advertisers and e-commerce companies. Founded in 2014 by Fredrik Skantze and Per Made, the company provides a platform that integrates with over 400 marketing and advertising sources. This allows businesses to automatically collect and structure advertising performance data, facilitating better decision-making regarding advertising spend and business growth. Funnel enables users to feed data into various tools, including Business Intelligence platforms, Data Warehouses, and visualization tools like Google Data Studio and Google Analytics. The company serves a diverse clientele, including e-commerce businesses, media agencies, brands, B2B enterprises, mobile applications, and gaming companies. Funnel operates from its headquarters in Stockholm, with an additional office in Boston.
Combinostics
Series A in 2019
Combinostics is a software tools for diagnostics support.
Ingrid Cloud
Venture Round in 2019
Ingrid Cloud AB, based in Stockholm, Sweden, specializes in a cloud-based computational application designed for wind simulation. Founded in 2014, the company offers an automated platform that streamlines the flow simulation and design optimization process. By converting computer-aided design (CAD) geometry into complex simulation models without requiring manual intervention, Ingrid Cloud's technology enhances accuracy, flexibility, and cost efficiency. This user-friendly service allows designers, architects, engineers, and researchers, even those without prior knowledge of computational fluid dynamics, to effectively predict flow and refine their designs.
Crosser
Series A in 2019
Crosser specializes in the design and development of streaming analytics and integration software suitable for edge, fog, or cloud environments. The Crosser platform facilitates real-time processing of both streaming and batch data, supporting applications in industrial IoT, data transformation, analytics, automation, and integration. By offering real-time analytics and decision-making capabilities, the platform is particularly beneficial for enterprises in sectors such as healthcare, industrial IoT, and smart buildings. This technology helps organizations minimize cloud service usage and reduce bandwidth costs, enhancing operational efficiency and effectiveness.
Athera Biotechnologies
Venture Round in 2019
Athera is a biopharmaceutical company focused on developing targeted anti-inflammatory biological candidate drugs and companion diagnostics for the prevention and treatment of cardiovascular disease (“CVD”). The Company initiated its current program in 2005, harnessing breakthrough innovations made at the world-renowned Karolinska Institutet, Solna, Sweden. The company currently has a proprietary clinical development stage program, PC-mAb, supported by an approved proprietary companion diagnostic kit.
NuvoAir
Venture Round in 2019
NuvoAir AB, founded in 2015 and based in Stockholm, Sweden, is a medical technology company focused on monitoring lung function through its Air Next home spirometer. The company operates an online platform to provide its products and services. NuvoAir Medical offers a comprehensive care model that integrates advanced monitoring technology and analytics with evidence-based interventions for managing chronic heart and lung conditions. This approach emphasizes personalized care, delivered by a multidisciplinary team, and collaborates with health plans and risk-bearing entities to implement flexible payment arrangements. By focusing on value-based specialty management, NuvoAir aims to improve patient outcomes while reducing healthcare costs.
Gesynta Pharma
Seed Round in 2019
Gesynta Pharma AB is a clinical-stage pharmaceutical company based in Solna, Sweden, focused on developing innovative treatments for chronic inflammatory conditions through the inhibition of the pro-inflammatory enzyme microsomal prostaglandin E synthase-1 (mPGES-1). Originating from research at Karolinska Institutet, the company's most advanced drug candidate, vipoglanstat (GS-248), is being developed as a non-hormonal treatment for endometriosis, a prevalent and painful condition affecting many women of reproductive age. In preclinical studies, vipoglanstat has shown significant reductions in endometriotic lesions, pain relief, and improved well-being, with plans for a clinical phase II study underway. Additionally, Gesynta Pharma is preparing to advance another drug candidate, GS-073, into clinical phase I for a different inflammatory condition in 2023. The company aims to provide safe and effective treatment options for patients facing serious diseases related to chronic inflammation. Founded in 2017, Gesynta Pharma is supported by various investors, including Hadean Ventures, Industrifonden, and Linc.
Funnel
Venture Round in 2019
Funnel is a marketing analytics and reporting software that aims to streamline data collection for online advertisers and e-commerce companies. Founded in 2014 by Fredrik Skantze and Per Made, the company provides a platform that integrates with over 400 marketing and advertising sources. This allows businesses to automatically collect and structure advertising performance data, facilitating better decision-making regarding advertising spend and business growth. Funnel enables users to feed data into various tools, including Business Intelligence platforms, Data Warehouses, and visualization tools like Google Data Studio and Google Analytics. The company serves a diverse clientele, including e-commerce businesses, media agencies, brands, B2B enterprises, mobile applications, and gaming companies. Funnel operates from its headquarters in Stockholm, with an additional office in Boston.
Formulate
Venture Round in 2018
Formulate provides an advanced AI-engine, Retail DecisionCloud, that helps retailers transform simple sales data into better merchandising decisions. It is a cloud product that that turns POS data into competitive intelligence and analytics using machine learning.
Apica
Series D in 2018
Apica AB is a technology company based in Stockholm, Sweden, with additional offices in London, New York, and Santa Monica. Founded in 2005, it specializes in providing a load testing and synthetic monitoring platform tailored for enterprise needs. Apica's solutions encompass a range of applications, including internal systems, websites, mobile devices, and IoT use cases. The company's flagship products, Apica LoadTest and Apica Synthetic, ensure the performance and uptime of business-critical applications, allowing enterprises to prepare for peak conditions and proactively monitor their systems. Apica's unified platform simplifies data management, enabling real-time analysis of telemetry data and automated root cause analysis. Its tools facilitate efficient troubleshooting and enhance observability, making it easier for organizations to manage complex IT infrastructures while reducing costs and improving performance.
DPOrganizer
Series A in 2018
DPOrganizer is a privacy management software company founded in 2015 and headquartered in Stockholm, Sweden. The software is designed to assist professionals throughout the privacy program lifecycle by enabling them to map, visualize, report, and manage the processing of personal data. This functionality helps clients improve control and compliance with privacy regulations, reduce risks, and utilize internal resources more efficiently. The platform aims to facilitate better collaboration and communication within organizations, ultimately supporting their growth in compliance with GDPR and other privacy requirements.
Trialbee
Venture Round in 2018
Trialbee is an independent software company dedicated to deliver solutions and services to the pharmaceutical industry. The company was founded in 2010 with the development of a method to increase speed and accuracy of patient recruitment to clinical trials.
Fishbrain
Series B in 2018
Fishbrain is a mobile app and social network designed for fishing enthusiasts. It offers users tools, insights, and support to enhance their fishing experiences. The app features an interactive map that helps anglers discover new fishing locations and track what others are catching, including the bait used. Additionally, Fishbrain emphasizes responsible fishing practices by promoting catch and release methods and the sustainable harvesting of fish species. The platform aggregates data on fishing catches from around the world, fostering a community where users can connect and share their fishing experiences.
DPOrganizer
Series A in 2017
DPOrganizer is a privacy management software company founded in 2015 and headquartered in Stockholm, Sweden. The software is designed to assist professionals throughout the privacy program lifecycle by enabling them to map, visualize, report, and manage the processing of personal data. This functionality helps clients improve control and compliance with privacy regulations, reduce risks, and utilize internal resources more efficiently. The platform aims to facilitate better collaboration and communication within organizations, ultimately supporting their growth in compliance with GDPR and other privacy requirements.
Barnebys
Venture Round in 2017
Barnebys is a leading online search aggregator for art, antiques, and collectibles, founded in Stockholm, Sweden in 2011. The company operates globally, with offices in New York, the UK, France, Spain, and Germany. Barnebys provides a platform that connects buyers and sellers in the auction industry, allowing them to conduct transactions through a user-friendly interface. The service caters to top-tier auctioneers, antique dealers, galleries, as well as regional and local businesses. In addition to its search capabilities, Barnebys offers an extensive free database of auction results and a premium valuation service, enhancing the tools available to its clients. The company continues to explore opportunities for growth and expansion in the auction market.
Adfenix
Series A in 2017
Adfenix AB, founded in 2014 and headquartered in Gothenburg, Sweden, specializes in a social media advertising platform tailored for real estate agents. The company enables these agents to effectively reach new customers through targeted social media campaigns. By leveraging comprehensive real estate data, Adfenix empowers agents to assist consumers in their home-buying journey. The platform provides quality advertising products and related services, streamlining the process for real estate professionals and enhancing their marketing capabilities.
Funnel
Series A in 2017
Funnel is a marketing analytics and reporting software that aims to streamline data collection for online advertisers and e-commerce companies. Founded in 2014 by Fredrik Skantze and Per Made, the company provides a platform that integrates with over 400 marketing and advertising sources. This allows businesses to automatically collect and structure advertising performance data, facilitating better decision-making regarding advertising spend and business growth. Funnel enables users to feed data into various tools, including Business Intelligence platforms, Data Warehouses, and visualization tools like Google Data Studio and Google Analytics. The company serves a diverse clientele, including e-commerce businesses, media agencies, brands, B2B enterprises, mobile applications, and gaming companies. Funnel operates from its headquarters in Stockholm, with an additional office in Boston.
Starcounter
Venture Round in 2017
Starcounter, founded in 2006 by Joachim Wester, is a privately held company based in Stockholm, Sweden, with additional offices in Gdansk, Poland, and Palo Alto, USA. The company specializes in developing a database management platform aimed at revitalizing enterprise software systems. Its innovative platform integrates an in-memory database engine with an application server, facilitating the creation of high-performance business applications. Starcounter's research and development team, composed of over 30 experts in artificial intelligence, mathematics, and algorithms from seven different countries, drives the company's advancements in technology. By leveraging artificial intelligence and in-memory computing, Starcounter enhances the efficiency and performance of software applications for enterprises.
Fast Travel Games
Series A in 2017
Fast Travel Games is a game development studio based in Stockholm, Sweden, specializing in virtual reality (VR) games. Founded by experienced professionals from notable studios such as EA DICE, Rovio, and Avalanche, the company aims to transform the gaming experience through immersive VR environments. They focus on creating games that promote exploration, rich narratives, and social interaction, allowing players to engage with their surroundings and each other in innovative ways. Fast Travel Games is dedicated to delivering engaging experiences that enhance the way players connect with gaming universes.
Apica
Venture Round in 2017
Apica AB is a technology company based in Stockholm, Sweden, with additional offices in London, New York, and Santa Monica. Founded in 2005, it specializes in providing a load testing and synthetic monitoring platform tailored for enterprise needs. Apica's solutions encompass a range of applications, including internal systems, websites, mobile devices, and IoT use cases. The company's flagship products, Apica LoadTest and Apica Synthetic, ensure the performance and uptime of business-critical applications, allowing enterprises to prepare for peak conditions and proactively monitor their systems. Apica's unified platform simplifies data management, enabling real-time analysis of telemetry data and automated root cause analysis. Its tools facilitate efficient troubleshooting and enhance observability, making it easier for organizations to manage complex IT infrastructures while reducing costs and improving performance.
Athera Biotechnologies
Venture Round in 2017
Athera is a biopharmaceutical company focused on developing targeted anti-inflammatory biological candidate drugs and companion diagnostics for the prevention and treatment of cardiovascular disease (“CVD”). The Company initiated its current program in 2005, harnessing breakthrough innovations made at the world-renowned Karolinska Institutet, Solna, Sweden. The company currently has a proprietary clinical development stage program, PC-mAb, supported by an approved proprietary companion diagnostic kit.
inRiver
Venture Round in 2017
inRiver AB develops a product information management (PIM) software solution that enables branded manufacturers, industrial manufacturers, and retailers to create, manage, and distribute product information effectively. The company serves B2C and B2B multi-channel commerce professionals, enhancing their ability to drive online sales and maintain customer satisfaction. Founded in 2003 and headquartered in Malmö, Sweden, inRiver has established regional offices in Chicago, Amsterdam, and Stockholm, along with sales offices in various global locations. The platform allows organizations to turn product information into strategic assets by uniformly presenting sales materials, such as videos, text, and images, across multiple channels and languages. With over 1,000 brands and 400 customers in 19 countries, inRiver helps businesses increase revenue and strengthen brand equity.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.